CRIS Current Research Information System

SCAIOLI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.163
EU - Europa 2.667
AS - Asia 2.278
SA - Sud America 147
AF - Africa 140
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.107
IT - Italia 1.092
SG - Singapore 641
VN - Vietnam 625
CN - Cina 477
GB - Regno Unito 446
SE - Svezia 247
DE - Germania 223
IN - India 142
HK - Hong Kong 140
FR - Francia 131
BR - Brasile 107
RU - Federazione Russa 106
IE - Irlanda 84
NL - Olanda 72
UA - Ucraina 71
ZA - Sudafrica 50
CA - Canada 35
CH - Svizzera 35
JO - Giordania 35
CI - Costa d'Avorio 30
BD - Bangladesh 29
EE - Estonia 29
JP - Giappone 26
PH - Filippine 25
BE - Belgio 23
TG - Togo 23
BG - Bulgaria 22
FI - Finlandia 22
TH - Thailandia 19
ES - Italia 17
AR - Argentina 16
AU - Australia 16
KR - Corea 16
ID - Indonesia 14
TR - Turchia 14
SA - Arabia Saudita 12
TW - Taiwan 11
MY - Malesia 10
AT - Austria 9
IR - Iran 9
PL - Polonia 9
SC - Seychelles 9
MX - Messico 8
NG - Nigeria 8
EC - Ecuador 7
KE - Kenya 7
CO - Colombia 6
IQ - Iraq 5
LB - Libano 5
LT - Lituania 5
RO - Romania 5
CL - Cile 4
HR - Croazia 4
HU - Ungheria 4
MU - Mauritius 4
BA - Bosnia-Erzegovina 3
BZ - Belize 3
HN - Honduras 3
IL - Israele 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
PK - Pakistan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BH - Bahrain 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LY - Libia 2
MA - Marocco 2
PY - Paraguay 2
AL - Albania 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GT - Guatemala 1
KZ - Kazakistan 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SL - Sierra Leone 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 8.413
Salva come PNG Salva come JPEG
Città #
Singapore 439
Southend 378
Ashburn 332
Fairfield 303
Chandler 244
Houston 228
Bologna 141
San Jose 135
Hong Kong 129
Santa Clara 129
Hanoi 128
Woodbridge 125
Seattle 123
Ho Chi Minh City 116
Cambridge 112
Ann Arbor 110
Wilmington 105
Beijing 90
Princeton 87
Dublin 78
Rome 64
Milan 59
Boardman 53
Dong Ket 53
Frankfurt am Main 50
Lauterbourg 44
Los Angeles 40
Westminster 38
Amman 34
Hefei 33
Abidjan 30
Padova 30
Nanjing 27
New York 26
Berlin 25
Buffalo 25
Tokyo 25
Council Bluffs 24
Dallas 24
Lomé 23
Bern 22
San Diego 21
Sofia 21
São Paulo 21
Capaccio 20
Palermo 20
Saint Petersburg 20
Turin 20
Jinan 19
Pune 19
Redondo Beach 18
Toronto 18
Da Nang 17
Changsha 16
Naples 15
Shenyang 15
Brussels 14
Haiphong 14
Hebei 14
Helsinki 14
Johannesburg 14
Orem 14
Redwood City 14
Chicago 12
Jiaxing 12
Modena 12
Bremen 11
Des Moines 11
Florence 11
The Dalles 11
Velletri 11
Dearborn 10
Medford 10
Phoenix 10
Redmond 10
Sydney 10
Bari 9
Bengaluru 9
Guangzhou 9
Nanchang 9
San Francisco 9
Seoul 9
Shanghai 9
Warsaw 9
Abeokuta 8
Atlanta 8
Kuala Lumpur 8
Munich 8
Bangkok 7
Castel Maggiore 7
Falkenstein 7
Ferrara 7
Genoa 7
Jacksonville 7
Kunming 7
London 7
Nairobi 7
Nha Trang 7
Norwalk 7
Potenza 7
Totale 4.988
Salva come PNG Salva come JPEG
Nome #
Polifenoli ed efficacia antinfiammatoria: lo strano caso del melograno e le malattie croniche intestinali 970
Pomegranate: from the Promised Land to calm the fire in Inflammatory Bowel Disease 315
COVID-19 in IBD: The experience of a single tertiary IBD center 306
Short-term treatment with eicosapentaenoic acid improves inflammation and affects colonic differentiation markers and microbiota in patients with ulcerative colitis 259
Clinical application of faecal calprotectin in ulcerative colitis patients 249
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 245
New Insight and Knowledge on anti-inflammatory Effectiveness of dietary phenolics: a work-in-progress report of the NIKE Project 230
Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy 230
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial 226
Attachment and mentalizing abilities in patients with inflammatory bowel disease 211
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 206
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch–Anal Anastomosis for Ulcerative Colitis 200
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 199
Gut Microbiota and Celiac Disease 194
Can fecal calprotectin better stratify Crohn’s disease activity index? 192
Body weight,lifestyle,dietary habits and gastroesophageal reflux disease 192
Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn’s disease, cause or epiphenomenon? 190
Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study 181
The Effect of Supplementing a Novel n-3 Polyunsaturated Fatty Acids Formulation Containing Schisandra chinensis Extract and Vitamin D3 to a Group of Elite Sport Athletes on Competition Related Stress, Anxiety and Self-confidence 180
null 179
Influence of K-ras status and anti-tumour treatments on complications due to colorectal self-expandable metallic stents: A retrospective multicentre study 172
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
Nerve fiber overgrowth in patients with symptomatic diverticular disease 169
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 166
Aortic thrombosis recurrence in a Crohn's disease patient 162
Non-invasive diagnostic approach to non-alcoholic fatty liver disease: Current evidence and future perspectives 160
Simkania negevensis in Crohn’s Disease 160
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods. 151
Calcolosi della colecisti complicata 150
Gut microbiota and its pathophysiology in disease paradigms. 150
Eicosapentaenoic free fatty acid to treat patients with SARS-Cov2 infection 148
PROBABILISTIC ASSESSMENT OF SYMPTOMLESS INFLAMMATION IN CROHN’S DISEASE PATIENTS 146
Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease - authors' reply. 144
Coeliac disease and autoimmune hepatitis: Gluten-free diet can influence liver disease outcome. 141
Bacteria flora,gas and antibiotics 139
Percutaneous liver biopsy in the clinical management of hepatocellular carcinoma:back to the future 133
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure 133
Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis 124
Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumor grading assessment 123
Calcolosi della colecisti 119
Calcolosi della via biliare principale 106
Natural history of small gallbladder polips is benign. Evidence from a clinical and pathogenetic study. 105
null 95
Extrahepatic cholangiocarcinoma: clinical features 86
MRI patterns in a case of 6-thioguanine-related hepatic sinusoidal obstruction syndrome 85
Totale 8.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 0 265
2021/20221.007 46 59 57 87 87 49 48 45 37 51 291 150
2022/20231.000 106 134 59 131 69 78 33 60 195 16 67 52
2023/2024449 25 51 51 39 45 83 31 23 27 33 15 26
2024/20251.202 69 164 81 85 217 58 103 51 42 79 55 198
2025/20262.438 175 156 177 195 254 173 267 112 555 197 85 92
Totale 8.590